Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$206.65
+1.0%
$191.08
$163.81
$218.66
$361.58B0.54.94 million shs4.43 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$73.40
-0.4%
$73.90
$57.65
$94.80
$33.63B1.134.25 million shs2.93 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$176.76
+1.2%
$161.28
$140.68
$177.27
$420.78B0.418.43 million shs9.48 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$701.51
+2.5%
$764.55
$623.78
$972.53
$647.78B0.446.35 million shs8.21 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$520.17
-0.4%
$502.60
$344.79
$555.45
$3.88T1.0620.74 million shs25.19 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$180.45
-0.9%
$163.96
$86.62
$184.48
$4.44T2.14153.66 million shs156.22 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$52.43
+2.9%
$64.96
$45.05
$139.74
$227.49B0.6326.34 million shs15.91 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.16
+0.2%
$24.60
$20.92
$30.43
$142.76B0.5245.23 million shs31.82 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$136.21
+1.7%
$133.88
$127.35
$159.64
$33.77B0.711.41 million shs13.93 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+0.92%+4.32%+8.46%+12.30%+7.11%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
-0.35%+1.94%-2.72%+0.37%-12.06%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.03%+1.94%+7.27%+16.78%+11.55%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+2.37%+12.21%-11.08%-7.36%-24.60%
Microsoft Corporation stock logo
MSFT
Microsoft
-0.44%-0.36%+2.88%+14.51%+24.78%
NVIDIA Corporation stock logo
NVDA
NVIDIA
-0.86%-1.22%+5.30%+33.27%+52.82%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+2.97%+2.68%-21.84%-18.52%-61.00%
Pfizer Inc. stock logo
PFE
Pfizer
+0.18%+2.40%+2.33%+10.23%-12.81%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
+1.68%+4.65%+1.46%+2.34%-10.25%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.7295 of 5 stars
2.54.03.33.93.92.51.3
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
3.5713 of 5 stars
2.43.01.70.03.61.72.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8419 of 5 stars
2.35.04.23.93.61.71.9
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.9986 of 5 stars
4.45.03.34.03.33.32.5
Microsoft Corporation stock logo
MSFT
Microsoft
4.9086 of 5 stars
3.54.03.32.93.52.51.9
NVIDIA Corporation stock logo
NVDA
NVIDIA
4.6086 of 5 stars
2.54.01.73.03.92.51.9
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4.7245 of 5 stars
4.05.02.50.03.70.03.1
Pfizer Inc. stock logo
PFE
Pfizer
4.9627 of 5 stars
3.23.04.24.53.21.73.1
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.96
Moderate Buy$214.954.02% Upside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.73
Moderate Buy$88.5520.63% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.65
Moderate Buy$174.50-1.28% Downside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.71
Moderate Buy$964.8837.54% Upside
Microsoft Corporation stock logo
MSFT
Microsoft
2.94
Moderate Buy$609.8617.24% Upside
NVIDIA Corporation stock logo
NVDA
NVIDIA
2.93
Moderate Buy$186.333.26% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.07
Hold$83.7559.74% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.39
Hold$28.1211.76% Upside
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
2.68
Moderate Buy$136.21N/A

Current Analyst Ratings Breakdown

Latest NVDA, NVO, ABBV, LLY, XLV, JNJ, MSFT, PFE, and GEHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/14/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$192.00 ➝ $205.00
8/13/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$975.00 ➝ $825.00
8/13/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$180.00 ➝ $225.00
8/13/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral
8/13/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$942.00 ➝ $875.00
8/13/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BNP Paribas Exane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$54.00
8/12/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$231.00
8/11/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/11/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$1,010.00 ➝ $900.00
8/11/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $220.00
(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B6.48$15.07 per share13.71($0.08) per share-2,583.13
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$19.67B1.70$5.76 per share12.75$21.32 per share3.44
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.79$13.27 per share13.32$32.58 per share5.43
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$45.04B14.74$14.59 per share48.08$19.39 per share36.18
Microsoft Corporation stock logo
MSFT
Microsoft
$281.72B13.72$18.21 per share28.56$46.21 per share11.26
NVIDIA Corporation stock logo
NVDA
NVIDIA
$130.50B33.74$3.03 per share59.53$3.25 per share55.52
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$42.12B5.56$4.01 per share13.06$5.73 per share9.15
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.25$4.38 per share5.75$15.66 per share1.61
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.1098.4114.781.326.45%699.66%13.64%10/29/2025 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.99B$4.8815.0414.122.8111.22%23.93%6.29%10/29/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$9.3518.9015.972.2325.00%32.49%13.00%10/21/2025 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$10.59B$15.3045.8522.540.9525.91%92.72%16.89%10/29/2025 (Estimated)
Microsoft Corporation stock logo
MSFT
Microsoft
$101.83B$13.6438.1435.392.2936.15%32.44%18.20%10/29/2025 (Estimated)
NVIDIA Corporation stock logo
NVDA
NVIDIA
$72.88B$3.1058.2145.341.6051.69%105.09%72.19%8/27/2025 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$14.64B$3.6414.4011.251.7535.60%78.64%24.51%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.8813.388.300.8916.84%21.42%9.12%11/4/2025 (Estimated)
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/A21.15N/AN/AN/AN/AN/A

Latest NVDA, NVO, ABBV, LLY, XLV, JNJ, MSFT, PFE, and GEHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/27/2025Q2 2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$1.00N/AN/AN/A$45.65 billionN/A
8/7/2025Q2 2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.59$6.31+$0.72$6.29$14.40 billion$15.56 billion
8/6/2025Q2 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.93$0.97+$0.04$0.91$77.51 billion$11.69 billion
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.58$0.78+$0.20$0.51$13.43 billion$14.65 billion
7/31/2025Q2 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$3.24$2.97-$0.27$0.52$14.93 billion$15.42 billion
7/30/2025Q2 2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.91$1.06+$0.15$1.06$4.96 billion$5.00 billion
7/30/2025Q4 2025
Microsoft Corporation stock logo
MSFT
Microsoft
$3.35$3.65+$0.30$3.65$73.79 billion$76.44 billion
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.77+$0.09$2.29$22.85 billion$23.74 billion
5/28/2025Q1 2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$0.87$0.81-$0.06$0.76$43.09 billion$44.06 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.17%N/A312.38%53 Years
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.19%N/A2.87%1 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.94%N/A55.61%64 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.000.86%N/A39.22%11 Years
Microsoft Corporation stock logo
MSFT
Microsoft
$3.320.64%N/A24.34%23 Years
NVIDIA Corporation stock logo
NVDA
NVIDIA
$0.040.02%N/A1.29%1 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.643.13%N/A45.05%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.84%N/A91.49%16 Years
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$2.391.75%N/AN/AN/A

Latest NVDA, NVO, ABBV, LLY, XLV, JNJ, MSFT, PFE, and GEHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/10/2025
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.830.71%8/21/20258/21/20259/11/2025
6/23/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.500.78%8/15/20258/15/20259/10/2025
7/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.35%8/26/20258/26/20259/9/2025
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
8/7/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
semi-annual$0.41192.4%8/18/20258/18/20258/26/2025
6/20/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.54%7/15/20257/15/20258/15/2025
7/1/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
quarterly$0.03500.19%7/25/20257/25/20258/15/2025
5/28/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
quarterly$0.010.03%6/11/20256/11/20257/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
44.14
0.74
0.61
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.85
1.16
0.93
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.50
1.01
0.76
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.86
1.28
1.00
Microsoft Corporation stock logo
MSFT
Microsoft
0.12
1.35
1.35
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.10
3.39
2.96
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.52
0.78
0.56
Pfizer Inc. stock logo
PFE
Pfizer
0.65
1.16
0.85
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
55,0001.77 billion1.76 billionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
53,000456.56 million455.28 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
47,000946.46 million945.23 millionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
228,0007.43 billion7.43 billionOptionable
NVIDIA Corporation stock logo
NVDA
NVIDIA
36,00024.40 billion23.38 billionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
77,3494.47 billion4.46 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A247.91 millionN/ANot Optionable

Recent News About These Companies

THW: Discounted Valuation Due To Higher Interest Rates
6 ETFs to Invest in June
Young woman doctor holding a tablet pc — Photo
Top Analyst-Rated Healthcare Stocks to Watch Now (XLV)
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$206.65 +1.97 (+0.96%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$206.10 -0.55 (-0.27%)
As of 08/15/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$73.40 -0.26 (-0.35%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$73.14 -0.26 (-0.36%)
As of 08/15/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$176.76 +2.04 (+1.17%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$176.06 -0.69 (-0.39%)
As of 08/15/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$701.51 +17.08 (+2.50%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$702.75 +1.24 (+0.18%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$520.17 -2.31 (-0.44%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$520.33 +0.16 (+0.03%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$180.45 -1.57 (-0.86%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$179.76 -0.69 (-0.38%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$52.43 +1.48 (+2.90%)
Closing price 08/15/2025 03:58 PM Eastern
Extended Trading
$56.14 +3.71 (+7.07%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Pfizer stock logo

Pfizer NYSE:PFE

$25.16 +0.05 (+0.20%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$25.13 -0.03 (-0.12%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Health Care Select Sector SPDR Fund stock logo

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$136.21 +2.25 (+1.68%)
Closing price 08/15/2025 04:10 PM Eastern
Extended Trading
$136.20 -0.01 (-0.01%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.